Synthesis and structure of a 1-D copper(II) coordination polymer bridged both by oxamido and carboxylate: in vitro anticancer activity and reactivity toward DNA and protein BSA

A 1-D copper(II) coordination polymer formulated as {[Cu₂(bdpox)(dabt)](NO₃)·H₂O}_n, where H₃bdpox and dabt denote N-benzoate-N′-[3-(diethylamino)propyl]oxamide and 2,2′-diamino-4,4′-bithiazole, respectively, was synthesized and characterized by elemental analyses, molar conductance measurement, IR and electronic spectra studies, and single-crystal X-ray diffraction. The crystal structure analysis reveals that copper(II) ions are bridged by both cis-oxamido and carboxylato groups to form a 1-D coordination polymer with corresponding Cu···Cu separations of 5.2420(10) and 5.1551(8) Å. The endo- and exo-copper(II) ions of the cis-oxamido-bridge are located in distorted square-planar and square-pyramidal geometries, respectively. There is a 2-D hydrogen bonding network in the crystal. The in vitro anticancer activities suggest that the copper(II) complex is active against selected tumor cell lines. The reactivities toward herring sperm DNA and bovine serum albumin (BSA) reveal that the copper(II) complex can interact with DNA by intercalation and effectively quench the intrinsic fluorescence of BSA via a static mechanism. The influence of hydrophobicity of the substituents in bridging ligands on DNA and protein binding properties and the in vitro anticancer activities of such copper(II) polymers is discussed.     

Natural and Synthetic Oligoarylamides: Privileged Structures for Medical Applications

The term “privileged structure” refers to a single molecular substructure or scaffold that can serve as a starting point for high-affinity ligands for more than one receptor type. In this report, a hitherto overlooked group of privileged substructures is addressed, namely aromatic oligoamides, for which there are natural models in the form of cystobactamids, albicidin, distamycin A, netropsin, and others. The aromatic and heteroaromatic core, together with a flexible selection of substituents, form conformationally well-defined scaffolds capable of specifically binding to conformationally well-defined regions of biomacromolecules such as helices in proteins or DNA often by acting as helices mimics themselves. As such, these aromatic oligoamides have already been employed to inhibit protein–protein and nucleic acid–protein interactions. This article is the first to bring together the scattered knowledge about aromatic oligoamides in connection with biomedical applications.     

[Ru(MeIm)4L]2+ (L=iip, tip, 2ntz)的电子结构、DNA-键合、构效关系及光谱特征

采用密度泛函的方法,结合导体极化连续模型研究了水溶性二价钌-甲基咪唑类配合物[Ru(MeIm)₄iip]²⁺ (1)、[Ru(MeIm)₄tip]²⁺(2)和[Ru(MeIm)₄2ntz]²⁺ (3)的电子结构、DNA的键合倾向及构效关系．在水溶液中几何优化的基础上分析了配合物的电子结构特征,并合理解释了配合物与DNA的键合倾向．计算结果表明,在主配体上用噻吩代替咪唑取代基可以有效提高配合物与DNA的键合力;同时,在主配体的骨架上引入强电负性的N原子及NO₂基团可以明显降低配合物最低未占据分子轨道能量及前沿分子轨道能量差．基于以上计算结果,预测所设计的配合物3具有最大的DNA键合力常数．另外,详细分析了配合物1、2的构效关系及抗肿瘤作用机理,并预测了配合物3的抗肿瘤活性．最后,用含时密度泛函方法对配合物的电子吸收光谱进行了计算和模拟,并与实验结果进行了对比分析.     

Synthesis, Crystal Structure and DNA-binding Property of Bismuth(Ⅲ) Complex with p-Hydroxy-phenylacetic Acid

A bismuth(Ⅲ) complex 1 (H2-4,4'-bipy)Bi(HPPA)5(H2PPA)·4H2O (H2PPA = p-hydroxy-phenylacetic acid, 4,4'-bipy = 4,4 -bipyridyl) was hydrothermally synthesized from p-hydroxy-phenylacetic acid (H 2 PPA), Bi(NO 3) 3 ·6H 2 O and 4,4 -bipyridyl, and characterized by elemental analysis, IR, molar conductivity and TG. The single-crystal X-ray diffraction studies demonstrated that the complex is of monoclinic system, space group P21 with a = 10.928(7), b = 22.558(7), c = 11.313(7), β = 91.864(4)°, V = 2787.7(4)3 , Z = 2, C58H61BiN2O22 , Mr = 1347.07, F(000) = 1364, Dc = 1.605 g/cm-3 , μ(MoKα) = 3.247 mm-1 , the final R = 0.0269 and wR = 0.0540 for 9776 observed reflections with Ⅰ > 2σ(Ⅰ). The bismuth(Ⅲ) is seven-coordinated with O atoms, forming a monocapped octahedral geometry. Complex 1 further forms a 3D supramolecular architecture by hydrogen bonds and π-π stacking interactions. Moreover, the interaction between the complex and DNA was studied by EtBr fluoescent probe.     

Structure,DNA-binding interaction and antitumour activity of two novel complexes coordinated by tridentate 1,3-bis(benzimidazol-2-yl)-2-oxapropane ligand

Two novel DNA-intercalating complexes, [Cd(hipa)(bbiop)] _n (1) and [Ni(ada)(bbiop)] _n ·2H₂O (2) with hipa, ada and potentially tridentate ligand bbiop (bbiop, 1,3-bis(benzimidazol-2-yl)-2-oxa-propane; hipa, 5-hydroxyisophthalate; ada, aniline-N,N-diacetate), have been synthesised under hydrothermal methods and structurally characterised by single crystal X-ray diffraction analysis, elemental analysis, UV–vis spectrum and fluorescent spectrum. The bbiop ligand exists as chelating-tridentate μ₁-(η₃–N₁, N₂, O₆) coordination fashion. In addition, their in vitro cytotoxicities towards four selected tumour cell lines have been evaluated by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide method. Complex 1 exhibits the most dramatic inhibitory effect on MG-63, and its inhibition rate is higher than that of its free ligands, H₂bbiop and hipa, indicating significantly enhanced effect after forming complex. On the basis of the combination of UV–vis absorption and fluorescence titrations, complex 1 can interact with the base pairs of double-helical DNA via an intercalative mode with intrinsic binding constant, K _b, of 4.62 × 10⁷, presenting the high DNA-binding affinity.     

基于席夫碱配体构筑的Ln2Ⅲ配合物的结构、荧光性质及生物活性

以多齿席夫碱配体 H₂L(H₂L=(E)-N′-(3-乙氧基-2-羟基亚苄基)-3-羟基吡啶甲酰肼)为配体,与 Ln(acac)₃·2 H₂O(Ln=Tb、Ho、Er;acac^-=乙酰丙酮根)反应,通过溶剂热法,成功得到了 3例新的双核稀土配合物[Ln₂(acac)₂(L)₂(C₂H₅OH)₂](Ln=Tb (1)、Ho(2)、Er(3))。单晶X射线衍射分析表明：配合物1~3的结构主要由2个Ln^Ⅲ离子、2个乙酰丙酮根(acac^-)、2个L^2-及2个C₂H₅OH组成,中心Ln^Ⅲ离子通过2个μ₂-O原子相互连接,形成一个平行四边形的Ln₂O₂核心。固体荧光实验测试结果表明：配合物1在室温下表现出Tb^Ⅲ离子的荧光特征发射峰。此外,生物活性研究表明,与配体H₂L和稀土离子相比较,配合物1~3具有更强的抗菌活性。采用紫外光谱法、循环伏安法、凝胶电泳法和荧光光谱法研究了配合物 1~3与小牛胸腺 DNA之间的相互作用,结果表明配合物主要以插入作用的方式与小牛胸腺DNA结合。     

由4-甲基-1,2,3-噻二唑-5-甲酸构筑的铜配合物的合成、晶体结构及与DNA作用

由4-甲基-1,2,3-噻二唑-5-甲酸（HMTC,C₄H₄N₂O₂S）和菲咯啉（Phen）合成了2个铜配合物[Cu（MTC）₂（H₂O）₂]_n （1）,[Cu₂（MTC）₂（Phen）₂（H₂O）₄]（MTC）₂ （2）。用元素分析、红外光谱、热重分析、粉末X射线衍射进行表征,用单晶X射线衍射方法测定了配合物的晶体结构。结果表明,配合物1是一维链状结构,属于单斜晶系P2₁/c空间群,中心金属铜（Ⅱ）离子的配位构型是一个畸变的四方锥结构。配合物2属于三斜晶系,P1空间群,是一个双核结构,由2个配位水分子上的氧桥连2个铜（Ⅱ）离子形成六配位的扭曲八面体结构。用溴化乙锭荧光探针测定了配体和配合物与DNA的相互作用,结果显示无论是配体还是配合物均能使EB-DNA复合体系的荧光发生不同程度的猝灭,且配合物的作用强度大于配体,具有刚性平面辅助配体的配合物2的作用强度又大于不加辅助配体的配合物1。     

A revised treatment of the non-electrostatic contribution to the solvation free energy of DNA-binding ligands

A revised magnitude of the microscopic surface tension coefficient, γ_vdW, is suggested to account for the van der Waals solvation energy, ΔG_vdW^solv, in the standard expression ΔG_vdW^solv = γ_vdW ⋅ ΔA, where ?A is the change in solvent accessible surface area on complexation. The revised value of γ_vdW = − 0.063(± 0.008) kcal/mol/Ų is based on the decomposition of the Gibbs free energy for 49 reactions of non-covalent bimolecular ligand-DNA and ligand-ligand complexation, involving 20 DNA-binding molecules that differ in structure and charge state. The total non-electrostatic contribution to the solvation free energy can also be calculated from the standard equation ΔG_nel^solv = γ_nel ⋅ ΔA with the revised coefficient γ_nel = − 0.013(± 0.008) kcal/mol/Ų. It is proposed that these results may be utilized for analysis of any ligand-DNA or ligand-ligand interaction, if the structure and other physical properties of the interacting molecules do not change on complexation.     

New Ru(II)–dmso complexes with heterocyclic hydrazone ligands towards cancer chemotherapy

The synthesis and characterization of ruthenium(II) complexes, [RuCl₂(dmso)₂(bfmh)] (1; dmso = dimethyl sulfoxide, bfmh = benzoic acid furan-2-ylmethylene-hydrazide), [RuCl₂(dmso)₂(btmh)](2; btmh = benzoic acid thiophen-2-ylmethylene-hydrazide), [RuCl₂(dmso)₂(bfeh)](3; bfeh = benzoic acid (1-furan-2-yl-ethylidene)-hydrazide) and [RuCl₂(dmso)₂(bpeh)](4; bpeh = benzoic acid (1-pyridin-2-yl-ethylidene)-hydrazide) are described. The ligands, when treated with either cis-[RuCl₂(dmso)₄] or trans(Cl)–[RuCl₂(dmso)₂(bpy)], resulted in the same products. This has been confirmed by IR spectra and single crystal X-ray diffraction studies. The redox behaviors of the complexes have been found to be strongly dependent on the electronic nature of the moieties present in the hydrazone ligands. The binding of the complexes to Herring sperm DNA has been studied by absorption titration and cyclic voltammetry. But, due to the random change in the absorption on the addition of DNA, only a qualitative result rather than a quantitative result has been obtained. All the complexes have been found to bind DNA through different modes to different extents. The antibacterial properties of the ligands and the complexes have been studied against five pathogenic bacteria and also the minimum inhibitory concentrations (MIC) of all the ligands and complexes 2 and 4 have been evaluated.     

由联苯-2,4,4',6-四甲酸构筑的三维镉配位聚合物的合成、结构及与DNA作用

在水热条件下,以联苯-2,4,4′,6-四甲酸(C16H10O12,H4bptc)为主配体、1,3-二(4-吡啶基)-丙烷(bpp)为辅助配体,与氯化镉(Cd Cl2·2.5H2O)反应合成了2个三维镉配位聚合物{[Cd2(bptc)(H2O)3]·H2O}n(1),{[Cd2(bptc)(bpp)·H2O]·2.25H2O}n(2)。用元素分析、红外光谱对配合物的组成及结构进行了表征,并通过X射线单晶衍射的方法测定了配合物的晶体结构。配合物1具有双核结构,2个中心离子Cd(Ⅱ)同为六配位,均形成略有畸变的八面体结构;而配合物2尽管也具有双核结构,但不同于1的是其中一个中心离子构成略显畸变的八面体几何结构,另一个却构成五角双锥结构。用溴化乙锭荧光光谱法测定了配体和配合物与DNA作用情况,结果表明配合物与DNA的作用强于配体。